Cargando…
Polycythemia Vera Presenting With Normal Hemoglobin and Hematocrit: A Rare Variant
Polycythemia vera (PV) is a myeloproliferative neoplasm, and its diagnosis requires elevated hemoglobin level (>16.5 mg/dL in men and >16 mg/dL in women), bone marrow characteristics of PV (hypercellularity for age with trilineage growth), and presence of JAK2 (Janus kinase 2) mutations or sub...
Autores principales: | Erdinc, Burak, Ramachandran, Preethi, Boris, Avezbakiyev |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331897/ https://www.ncbi.nlm.nih.gov/pubmed/32637283 http://dx.doi.org/10.7759/cureus.8404 |
Ejemplares similares
-
Splenectomy Normalizes Hematocrit in Murine Polycythemia Vera
por: Mo, Jan-Rung, et al.
Publicado: (2009) -
Polycythemia Vera: Thinking Beyond the Hematocrit
por: Waggoner, Matthew
Publicado: (2023) -
A Rare Association Between Prostate Cancer and Polycythemia Vera
por: Elhaj, Maab F, et al.
Publicado: (2020) -
Advances in the Treatment of Polycythemia Vera: Trends in Disease Management
por: Arya, Yajur, et al.
Publicado: (2021) -
JAK2 and TET2 Mutation in Polycythemia Vera
por: Padda, Jaskamal, et al.
Publicado: (2021)